StockDuty ← Dashboard Aug 19, 2026 08:16 PM ET
CatalystFDA/Bio

MRNA CANCER VACCINE SUCCEEDED IN PHASE 3 MELANOMA TRIAL, MODERNA AND MERCK SAY - ARSTECHNICA

Phase 3 melanoma trial success with Moderna and Merck confirms efficacy catalyst.

What changed
Why it matters
Phase 3 melanoma trial success with Moderna and Merck confirms efficacy catalyst.
Sources
arstechnica
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →